News

 

• June 15, 2017 – BioSculpture Technology will present at the Marcum MicroCap Conference 2017 at the Grand Hyatt in New York City, NY.

​

• November 1, 2016 - BioSculpture Technology featured in an article on Equities.com.

​

• October 10, 2016 - Silvia Davi of Equities.com interviewed Dr. Robert Cucin, CEO at the NASDAQ marketsite in NYC.

 

• September 12, 2016 – SNNLive spoke with Dr. Robert Cucin, President & CEO during Media Day 2016 at WestPark Capital in New York City, NY.

​

• September 1, 2016 - S.E.C. qualifies BioSulpture Technology, Inc's Tier 2 Regulation A Offering.

​

• June 30, 2016 - BioSculpture Technology files its Form 1-A with the S.E.C. for a Tier 2 Regulation A Offering to fund development and clinical testing of its endoscopic treatment of obesity, metabolic syndrome and type 2 diabetes mellitus.

 

• June 1-2, 2016 - For the second year in a row, BioSculpture Technology will present at Marcum's MicroCap conference at the Grand Hyatt in N.Y.C.

 

• June 25, 2015 - BioSculpture Technology will present at the NIBA's June 24-26 Conference in Newport Beach, California.

 

• June 12, 2015 - Robert L. Cucin, CEO of BioSculpture Technology, Inc. appeared on the Bootstrapping Segment on tastytrade.com and discussed his personal journey and commitment to offering visceral lipectomy to the billions of people suffering from obesity, the anticipated regulatory pathway, a projected timeline, and the required resources to achieve this goal.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

• May 27, 2015 - BioSculpture Technology, Inc. will present at the Marcum MicroCap conference at the Grand Hyatt in N.Y.C.

 

• April 11,  2015 - Robert L. Cucin, M.D., the C.E.O. of BioSculpture Technology was interviewed on the I Heart Radio "Trader's Network Show.  He elaborates on the both the rationale and potential of the Endoscopic Visceral Lipectomy methods and devices under development.